Allergen detection method
11175271 · 2021-11-16
Assignee
Inventors
Cpc classification
G01N30/7233
PHYSICS
G01N30/88
PHYSICS
International classification
G01N30/88
PHYSICS
G01N27/62
PHYSICS
Abstract
A highly-sensitive-allergen-measurement method is provided. A method for detecting an allergen in a sample comprises treating the sample with a protease, and detecting the presence or absence of an allergen-derived polypeptide in the enzymatically treated sample by a chromatographic separation analysis, wherein the allergen is one or more members selected from the group consisting of buckwheat, crustacean, milk, egg and peanut.
Claims
1. A method for detecting an allergen in a sample, the method comprising treating the sample with a protease, thereby producing an enzymatically treated sample, and detecting the presence or absence of an allergen-derived polypeptide in the enzymatically treated sample by chromatographic separation analysis, wherein the allergen comprises buckwheat, and the allergen-derived polypeptide comprises any one or more of polypeptides consisting of amino acid sequences represented by SEQ ID NOs: 4 or 6.
2. The method according to claim 1, wherein the allergen comprises buckwheat and crustacean, wherein the allergen-derived polypeptide comprises any one or more of polypeptides consisting of amino acid sequences represented by SEQ ID NOs: 4 or 6, and further comprises any one or more polypeptides with amino acid sequences selected from the group consisting of SEQ ID NOs: 8 to 12.
3. The method according to claim 1, wherein the allergen-derived polypeptide comprises any one or more polypeptides consisting of amino acid sequences represented by SEQ ID NOs: 4 or 6, and further comprises any one or more polypeptides with amino acid sequences selected from the group consisting of SEQ ID NOs: 1, 2, 3, 5, and 7.
4. The method according to claim 2, wherein the allergen-derived polypeptide comprises any one or more polypeptides consisting of amino acid sequences represented by SEQ NOs: 4 or 6, and further comprises any one or more polypeptides with amino acid sequences selected from the group consisting of SEQ ID NOs: 1, 2, 3, 5, and 7 to 12.
5. The method according to claim 1, wherein the chromatographic separation analysis is liquid chromatography tandem mass spectrometry.
6. The method according to claim 1, wherein the protease is trypsin.
Description
BRIEF DESCRIPTION OF DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
DESCRIPTION OF EMBODIMENTS
(10) The present invention provides a method for detecting an allergen in a sample. According to the method of the present invention, one or more allergen members selected from the group consisting of buckwheat, crustacean, milk, egg and peanut can be detected. In a preferred embodiment, the allergen detected by the method of the present invention is one or more members selected from the group consisting of at least buckwheat and crustacean, more preferably one or more members selected from the group consisting of buckwheat and crustacean, still more preferably either buckwheat or crustacean. Alternatively, the allergen detected by the method of the invention includes at least buckwheat, and may be, for example, buckwheat alone, buckwheat and crustacean, or buckwheat, crustacean, milk, egg and peanut.
(11) In the present invention, examples of an object to be subjected to allergen detection include a food product, cosmetic, medicine, raw material thereof, and instrument used in a manufacturing process thereof; however, the examples are not limited thereto. Such an object subjected to a conventional pretreatment, for example, grinding, dissolution, suspension, extraction, or a combination thereof, can be used as a sample for the method of the present invention. Alternatively, in a case where the object is an instrument, for example, its washing solution or wiped sample, or those subjected to grinding, dissolution, suspension, extraction etc., or a combination thereof can be used as a sample for the method of the present invention. A method for preparing the sample used in the method of the present invention is not limited to the above, and may include any method that can be used for preparing a sample for a protease treatment described below.
(12) In the method of the present invention, the prepared sample is treated with a protease. Examples of the protease used in the method of the present invention include trypsin, chymotrypsin, elastase and thermolysin, preferably trypsin. Conditions for the treatment may be appropriately selected depending on the type of enzyme. For in a case of trypsin, the conditions preferably include an enzyme concentration of 1000 to 20000 U, temperature of 25 to 45° C., pH of about 7 to 9 and period of time of 4 to 24 hours. The enzymatic treatment cleaves a protein molecule of the target allergen to produce polypeptides derived from the allergen. Accordingly, if the target allergen is contained in a sample, the enzymatically treated sample contains polypeptides derived from the target allergen. On the other hand, if the target allergen is not contained in a sample, the enzymatically treated sample does not contain polypeptides derived from the target allergen.
(13) Accordingly, it is possible to determine the presence or absence of the target allergen in a sample by detecting the presence or absence of a target allergen-derived polypeptide in the sample treated with the protease described above.
(14) As to buckwheat, a cleavage product of a buckwheat 22 kDa protein molecule (SEQ ID NO: 25) can be detected as an allergen-derived polypeptide. In a preferred embodiment of the method of the present invention, in a case where the allergen is buckwheat, a polypeptide consisting of the amino acid sequence represented by any of SEQ ID NOs: 1 to 7 described below is detected as an allergen-derived polypeptide.
(15) TABLE-US-00001 (SEQ ID NO: 1) VQVVGDEGR (SEQ ID NO: 2) SVFDDNVQR (SEQ ID NO: 3) GQILVVPQGFAVVLK (SEQ ID NO: 4) EGLEWVELK (SEQ ID NO: 5) NFFLAGQSK (SEQ ID NO: 6) GFIVQAR (SEQ ID NO: 7) NDDNAITSPIAGK
(16) In the method of the present invention, the presence or absence of any one or more of polypeptides consisting of the amino acid sequences represented by above-described SEQ ID NOs: 1 to 7 may be detected. Preferably, the presence or absence of all of these polypeptides is detected.
(17) As to crustacean such as crab and shrimp, a cleavage product of tropomyosin can be detected as an allergen-derived polypeptide. In a preferred embodiment of the method of the present invention, in a case where the allergen is crustacean, a polypeptides consisting of the amino acid sequence represented by any of SEQ ID NOs: 8 to 12 described below is detected as an allergen-derived polypeptide.
(18) TABLE-US-00002 (SEQ ID NO: 8) IQLLEEDLER (SEQ ID NO: 9) MDALENQLK (SEQ ID NO: 10) FLAEEADR (SEQ ID NO: 11) IVELEEELR (SEQ ID NO: 12) LAMVEADLER
(19) In the method of the present invention, the presence or absence of any one or more of polypeptides consisting of the amino acid sequences represented by above-described SEQ ID NOs: 8 to 12 may be detected. Preferably, the presence or absence of all of these polypeptides is detected.
(20) In a case where the allergen is buckwheat and crustacean, the allergen-derived polypeptide to be detected is preferably any one or more of polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 1 to 7 and any one or more of polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 8 to 12, more preferably, all of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 1 to 12.
(21) As to milk, a cleavage product of casein or β-lactoglobulin (BLG) can be detected as an allergen-derived polypeptide. In a preferred embodiment of the method of the present invention, in a case where the allergen is milk, a polypeptide consisting of the amino acid sequence represented by any of SEQ ID NOs: 13 to 17 described below is detected as an allergen-derived polypeptide. Among the following polypeptides, SEQ ID NOs: 13 to 15 are the amino acid sequences of casein-derived polypeptides, and SEQ ID NOs: 16 to 17 are the amino acid sequences of BLG-derived polypeptides.
(22) TABLE-US-00003 (SEQ ID NO: 13) FFVAPFPEVFGK (SEQ ID NO: 14) YLGYLEQLLR (SEQ ID NO: 15) NAVPITPTLNR (SEQ ID NO: 16) VLVLDTDYK (SEQ ID NO: 17) TPEVDDEALEK
(23) In the method of the present invention, the presence or absence of any one or more of polypeptides consisting of the amino acid sequences represented by above-described SEQ ID NOs: 13 to 17 is detected. Preferably, the presence or absence of all of these polypeptides is detected. As to casein, the presence or absence of preferably any one or more of polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 13 to 15, more preferably all of these polypeptides is detected. As to BLG, the presence or absence of preferably any one or more of polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 16 to 17, more preferably all of these polypeptides is detected.
(24) As to egg, a cleavage product of ovalbumin can be detected as an allergen-derived polypeptide. In a preferred embodiment of the method of the present invention, in a case where the allergen is egg, a polypeptide consisting of the amino acid sequence represented by any of SEQ ID NOs: 18 to 21 described below is detected as an allergen-derived polypeptide.
(25) TABLE-US-00004 (SEQ ID NO: 18) YPILPEYLQCVK (SEQ ID NO: 19) ELINSWVESQTNGIIR (SEQ ID NO: 20) LTEWTSSNVMEER (SEQ ID NO: 21) HIATNAVLFFGR
(26) In the method of the present invention, the presence or absence of any one or more of polypeptides consisting of the amino acid sequences represented by above-described SEQ ID NOs: 18 to 21 is detected. Preferably, the presence or absence of all of these polypeptides is detected.
(27) As to peanut, a cleavage product of Ara h1-3 can be detected as an allergen-derived polypeptide. In a preferred embodiment of the method of the present invention, in a case where the allergen is peanut, a polypeptide consisting of the amino acid sequence represented by any of SEQ ID NOs: 22 to 24 described below is detected as an allergen-derived polypeptide. Among the following polypeptides, SEQ ID NOs: 22 to 23 are the amino acid sequences of Ara h1-derived polypeptides, and SEQ ID NO: 24 is the amino acid sequence of an Ara h3-derived polypeptide.
(28) TABLE-US-00005 (SEQ ID NO: 22) DLAFPGSGEQVEK (SEQ ID NO: 23) VLLEENAGGEQEER (SEQ ID NO: 24) SPDTYNPQAGSLK
(29) In the method of the present invention, the presence or absence of any one or more of polypeptides consisting of the amino acid sequences represented by above-described SEQ ID NOs: 22 to 24 is detected. Preferably, the presence or absence of all of these polypeptides is detected. As to Ara h1, the presence or absence of preferably any one or more of polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 22 to 23, more preferably all of these polypeptides is detected. As to Ara h3, the presence or absence of the polypeptide preferably consisting of the amino acid sequence represented by SEQ ID NO: 24 is detected.
(30) Accordingly, when the allergen is buckwheat, crustacean, milk, egg and peanut, the allergen-derived polypeptide to be detected is preferably any one or more of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 1 to 7, any one or more of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 8 to 12, any one or more of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 13 to 17, any one or more of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 18 to 21, and any one or more of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 22 to 24; more preferably all of the polypeptides consisting of the amino acid sequences represented by SEQ ID NOs: 1 to 24.
(31) As a means for detecting the presence or absence of the target allergen-derived polypeptide in the sample treated with the protease described above, a chromatographic separation analysis is preferable. Examples of the chromatographic separation analysis include liquid chromatography-mass spectrometry such as liquid chromatography tandem mass spectrometry (LC-MS/MS) or liquid chromatography time-of-flight mass spectrometry (LC-TOF/MS). Multiple reaction monitoring (MRM) using LC-MS/MS is preferable because it has high measurement accuracy (S/N ratio) and can detect multiple peptides at once.
(32) In the method of the present invention, as the chromatography used for detection of the target allergen-derived polypeptide, liquid chromatography (LC) is preferable, and reversed phase liquid chromatography (RPLC) is more preferable. Also, the LC is preferably high performance liquid chromatography (HPLC), more preferably RP-HPLC. Examples of a carrier for RPLC include a carrier having a filler in which a hydrocarbon chain (preferably an octadecyl group) is bonded to silica gel or a polymer gel base material, such as a C18 column or C8 column. Any mobile phase (eluent) for the LC may be used as long as it is capable of individually separating the target allergen-derived polypeptides, and examples thereof includes, however is not limited to, a 100:0 to 0:100 (volume ratio) gradient solution of an aqueous solution of formic acid (A) and an aqueous solution of formic acid acetonitrile (B).
(33) In liquid chromatography-mass spectrometry, the eluate from the LC is subjected to mass spectrometry (for example, MS/MS, TOF/MS). Mass spectrometry can be performed, under the usual conditions used in peptide detection, using a publicly known mass spectrometer, for example, tandem quadrupole mass spectrometer or time-of-flight mass spectrometer. For example, multiple reaction monitoring (MRM) using electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI) is preferred. In mass spectrometry, each polypeptide in the eluate is separated according to the mass/charge (m/z). For example, the presence or absence of the target polypeptide in a sample can be detected based on the measured m/z value by preliminarily making a database of the m/z value of the target polypeptide.
EXAMPLES
(34) Hereinafter, a more detailed description of the present invention is made with reference to Examples; however, the present invention is not limited to the following Examples.
(35) (Reagent)
(36) Acetonitrile (Wako Pure Chemical Corporation, special grade, for HPLC)
(37) Trypsin (Wako Pure Chemical Corporation, derived from porcine spleen, for biochemical analysis)
(38) Iodoacetamide (IA) (Wako Pure Chemical Corporation, for biochemical analysis)
(39) Dithiothreitol (DTT) (Wako Pure Chemical Corporation, for biochemical analysis)
(40) Urea (Wako Pure Chemical Corporation, special grade)
(41) Trifluoroacetic acid (TFA) (Junsei Chemical Co., Ltd., special grade)
(42) (Buffer)
(43) A: 0.1M DTT_0.5M Tris-HCl_4M urea (pH 8.2) buffer
(44) B: 0.5M Tris-HCl_2M urea (pH 8.2) buffer
Reference Example 1 Preparation of Allergen-Containing Sample
(45) 0.5 g of a specimen was collected in a 15 mL disposable test tube, and 5 mL of Buffer A (Test Examples 1 to 3) or Buffer B (Test Examples 4 to 5) was added, followed by shake extraction for 3 hours (Test Examples 1 to 3) or 5 hours (Test Examples 4 to 5). The obtained reaction product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was collected.
Example 1 Analysis of Trypsin Digest by LC-MS/MS
(46) 1) Trypsin Digestion
(47) 1 mg of allergen molecule or 0.25 mL of supernatant prepared in Reference Example 1 was collected in a polytube for 1.5 mL, and 0.25 mL of Buffer A (Test Examples 1 to 3) or Buffer B (Test Examples 4 to 5) was added for complete dissolution. To the obtained solution, 50 μL of 40 mg/mL DTT was added, followed by incubation at 37° C. for 90 minutes. Subsequently, 50 μL of 40 mg/mL IA was added, followed by incubation at 37° C. for 30 minutes in the absence of light. To the reaction solution, 600 μL of 50 mM sodium hydrogen carbonate was added, then 100 μL of a 10 mg/mL trypsin 50 mM sodium hydrogen carbonate solution was added, followed by incubation at 37° C. for 16 hours (pH 7 to 9). After the reaction, 10 μL of TFA was added for inactivation of trypsin.
(48) 2) Desalting
(49) OASIS HLB (3 cc, 60 mg; Waters) was conditioned with 1 mL of methanol and 2 mL of water. To this, the whole amount of the reaction solution obtained in 1) was dropwise added, followed by washing with 1 mL of water and subsequent elution with 1 mL of 60% acetonitrile.
(50) 3) Multiple Reaction Monitoring (MRM) by LC-MS/MS
(51) The eluate obtained in 2) was dried with nitrogen at 40° C., followed by dissolution in 0.2 mL of 25% acetonitrile. After the obtained solution was filtered, LC-MS/MS MRM was performed under the following conditions.
(52) (Lc-Ms/Ms Apparatus)
(53) HPLC: Shimadzu Nexera X2
(54) MS/MS: AB SCIEX QTRAP 5500
(55) (Hplc Conditions)
(56) Column: Kinetik C 18 150 mm×2.1 mm, particle diameter 2.6 μm
(57) Column temperature: 50° C.
(58) Column flow rate: 0.3 mL
(59) Eluent A: 0.1% formic acid; eluent B: 0.1% formic acid acetonitrile
(60) Gradient: A:B 95:5 (0 min).fwdarw.40:60 (20 min.).fwdarw.20:80 (50 min).fwdarw.95:5 (55 min) 95:5 (90 min)
(61) (Mass Analysis Conditions)
(62) Ionization method: electrospray ionization method
(63) Polarity: Positive
(64) Spray voltage: 5500 V
(65) Turbo heater temperature: 450° C.
Test Example 1 Detection or Buckwheat Allergen
(66) Using the 22 kDa protein (SEQ ID NO: 25) as a target allergen molecule, target allergen-derived polypeptides were detected by LC-MS/MS MRM under the condition shown in Table 1. The result is shown in
(67) TABLE-US-00006 TABLE 1 DETECTED MRM TRANSITION POLYPEPTIDE Q1 Q3 VQVVGDEGR 479.5 632.1 (SEQ ID NO: 1) 533.0 SVFDDNVQR 540.0 746.2 (SEQ ID NO: 2) 631.1 GQILVVPQGFAVVLK 784.5 1057.8 (SEQ ID NO: 3) 958.6 EGLEWVELK 551.6 674.3 (SEQ ID NO: 4) 488.1 NFFLAGQSK 506.6 750.4 (SEQ ID NO: 5) 603.2 GFIVQAR 395.9 586.2 (SEQ ID NO: 6) 473 NDDNAITSPIAGK 658.2 786.4 (SEQ ID NO: 7) 673.2
Test Example 2 Detection of Crustacean Allergen
(68) Using tropomyosin (SEQ ID NO: 26) as a target allergen molecule, target allergen-derived polypeptides were detected by LC-MS/MS MRM under the conditions shown in Table 2. The result is shown in
(69) TABLE-US-00007 TABLE 2 DETECTED MRM TRANSITION POLYPEPTIDE Q1 Q3 IQLLEEDLER 629.2 1016.6 (SEQ ID NO: 8) 903.4 MDALENQLK 531 815.2 (SEQ ID NO: 9) 744.1 FLAEEADR 475.5 690.2 (SEQ ID NO: 10) 619.1 IVELEEELR 565.1 917.5 (SEQ ID NO: 11) 788.4 LAMVEADLER 573.6 1033.6 (SEQ ID NO: 12) 831.4
Test Example 3 Detection of Buckwheat Allergen and Crustacean Allergen from Food Composition
(70) From wheat flour to which 0.01% by mass of buckwheat or crustacean (shrimp powder) was added, an allergen-containing sample was prepared according to Reference Example 1. The obtained sample was subjected to trypsin digestion, desalting and LC-MS/MS MRM according to Example 1, with the result that the target allergen-derived polypeptides were detected. The same analysis was performed using wheat flour to which no buckwheat or crustacean was added as a control. The allergen-derived polypeptides detected and conditions of LC-MS/MS analysis for buckwheat and crustacean were the same as those described above for Tables 1 and 2, respectively. The measurement results are shown in
Test Example 4 Detection of Milk, Egg and Peanut Allergens
(71) An allergen-containing sample was prepared according to Reference Example 1 from each of whole milk powder, whole egg powder and peanut flour. Each sample was subjected to trypsin digestion, desalting and LC-MS/MS MRM according to 1) to 3) in Example 1, with the result that the target allergen-derived polypeptides were detected. The target allergen molecules and detected allergen-derived polypeptides for each of the whole milk powder, whole egg powder and peanut flour are shown in Tables 3 to 5. All allergens of the whole milk powder, whole egg powder and peanut flour could be detected by LC-MS/MS analysis (
(72) TABLE-US-00008 TABLE 3 MILK ALLERGEN TARGET ALLERGEN DETECTED MRM TRANSITION MOLECULE POLYPEPTIDE Q1 Q3 CASEIN FFVAPFPEVFGK 692.9 920.3 (SEQ ID NO: 13) 991.3 YLGYLEQLLR 634.3 249.2 (SEQ ID NO: 14) 991.3 NAVPITPTLNR 598.3 158.3 (SEQ ID NO: 15) 911.4 β-LACTOGLOBULIN VLVLDTDYK 533.3 853.4 (BLG) (SEQ ID NO: 16) — TPEVDDEALEK 623.5 819.4 (SEQ ID NO: 17) —
(73) TABLE-US-00009 TABLE 4 EGG ALLERGEN TARGET ALLERGEN DETECTED MRM TRANSITION MOLECULE POLYPEPTIDE Q1 Q3 OVALBUMIN YPILPEYLQCVK 733.4 1092.7 (SEQ ID NO: 18) 979.5 ELINSWVESQTNGIIR 930.0 888.5 (SEQ ID NO: 19) 1017.5 LTEWTSSNVMEER 791.4 951.4 (SEQ ID NO: 20) 1052.5 HIATNAVLFFGR 673.4 223.2 (SEQ ID NO: 21) 1095.6
(74) TABLE-US-00010 TABLE 5 PEANUT ALLERGEN TARGET ALLERGEN DETECTED MRM TRANSITION MOLECULE POLYPEPTIDE Q1 Q3 Ara h1 DLAFPGSGEQVEK 688.8 930.5 (SEQ ID NO: 22) 300.2 VLLEENAGGEQEER 786.9 989.5 (SEQ ID NO: 23) 804.4 Ara h3 SPDIYNPQAGSLK 695.4 977.5 (SEQ ID NO: 24) 700.4
Test Example 5 Detection of Milk and Peanut Allergens from Food Composition
(75) Bread to which either whole milk powder or peanut flour was added (added bread; additive amount of 0.84% by mass) and bread to which neither milk nor peanut was contained (non-added bread) were produced. The added bread and non-added bread were mixed to prepare 100-fold diluted added bread (additive amount of whole powdered milk and peanut flour of 0.0084% by mass). The concentration of a milk or peanut allergen (soluble protein of peanut containing casein and Ara h) contained in the obtained 100-fold diluted added bread was measured by ELISA (with lower limit of quantification of 1 ppm). The measurement result is shown in Table 6.
(76) TABLE-US-00011 TABLE 6 100-FOLD NON-ADDED DILUTED ADDED BREAD ADDED BREAD BREAD ALLERGEN (ppm) (ppm) (ppm) MILK N.D. 625 6.5 PEANUT N.D. 745 8.7
(77) Next, allergen-containing samples were prepared, according to Reference Example 1, from non-added bread and 100-fold diluted added bread. The obtained samples were subjected to trypsin digestion, desalting and LC-MS/MS MRM according to Example 1, with the result that the target allergen-derived polypeptides were detected. As objects to be detected, casein-derived polypeptides (SEQ ID NOs: 13 to 15) were selected for milk, and Ara h1- or h3-derived polypeptides (SEQ ID NOs 22 to 24) were selected for peanut.
(78) As a result, peaks of the milk allergen (casein) and peanut allergen (Ara h1 or h3) could be confirmed with sufficient sensitivity for the 100-fold diluted added bread (